Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

iNeo Vac R01

Next Previous
Drug Profile

iNeo Vac R01

Alternative Names: iNeo-Vac-R01

Latest Information Update: 03 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hangzhou Neoantigen Therapeutics
  • Class Antineoplastics; Cancer vaccines; Immunotherapies; Peptide vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Cholangiocarcinoma; Liver cancer
  • Phase I Digestive system neoplasms

Most Recent Events

  • 09 Apr 2025 Phase-I/II clinical trials in Liver cancer (Late-stage disease, Inoperable/Unresectable, Metastatic disease, First-line therapy) in China (Parenteral) (NCT06995105)
  • 09 Apr 2025 Phase-I/II clinical trials in Cholangiocarcinoma (Late-stage disease, First-line therapy, Combination therapy) in China (Parenteral) (NCT06956716)
  • 25 Mar 2025 Zhejiang University plans a phase I/II trial for Pancreatic cancer (Adjuvant therapy, Combination therapy) in China (Parenteral, Injection) in April 2025 (NCT06888674)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top